...
机译:miR-26b通过胶质瘤细胞靶向WEE1反转替莫唑胺抗性
Soochow Univ Cyrus Tang Hematol Ctr Suzhou Peoples R China;
Soochow Univ Cyrus Tang Hematol Ctr Suzhou Peoples R China;
Soochow Univ Cyrus Tang Hematol Ctr Suzhou Peoples R China;
Soochow Univ Cyrus Tang Hematol Ctr Suzhou Peoples R China;
Soochow Univ Cyrus Tang Hematol Ctr Suzhou Peoples R China;
Soochow Univ Cyrus Tang Hematol Ctr Suzhou Peoples R China;
Soochow Univ Cyrus Tang Hematol Ctr Suzhou Peoples R China;
Jilin Prov Canc Hosp Dept Abdominal Oncosurg 1808 Huguang Rd Changchun Jilin Peoples R China;
Bengbu Med Coll Dept Biochem &
Mol Biol Bengbu Anhui Peoples R China;
Soochow Univ Cyrus Tang Hematol Ctr Suzhou Peoples R China;
Glioma; growth; miR-26b; temozolomide; Wee1;
机译:miR-26b通过胶质瘤细胞靶向WEE1反转替莫唑胺抗性
机译:替莫唑胺涂层纳米氧化锌逆转恶性神经胶质瘤干细胞抵抗力的研究
机译:替代灭菌型纳米氧化锌的研制,用于逆转恶性胶质瘤干细胞的抗性
机译:有针对性的聚合SMA-阿克拉霉素胶束的交付,以逆转抗癌药的耐药性
机译:MGMG靶向球形核酸克服胶质母细胞瘤中替莫唑胺的耐药性。
机译:MiR-26b通过靶向胶质瘤细胞中的Wee1逆转替莫唑胺耐药性
机译:miR-26b通过胶质瘤细胞靶向WEE1反转替莫唑胺抗性